CVCs Versus Midline Catheters
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAlbert Einstein College of Medicine
About this trial
The goal of this clinical trial is to learn if midline catheters can reduce adverse patient outcomes in adult patients requiring a single vasopressor. The main questions the study aims to answer are:
* Do midline catheters reduce the rates of catheter-related bloodstream infections as compared to central venous catheters? * Do midline catheters reduce the rates of deep venous thrombosis as compared to central venous catheters? Researchers will compare midline catheters to central venous catheters to see if there is a reduction in these events.
Participants will be randomized to the midline catheter group or the central venous catheter group. The catheters will be part of standard of care for vasopressor therapy. The participants will be followed for 30 days.
Eligibility criteria
Qualifiers
Patients over 18 years of age being treated in the Emergency Department at Jacobi Medical Center
Have an upper extremity (left or right arm) that can accept a midline catheter
Able to provide consent (patient or health care proxy)
Clinical team believes the patient will require inpatient admission at the time of needing intravenous access
Disqualifiers
Patients in cardiac arrest (prior to achieving ROSC)
Patients with infection or burns at both upper extremities
Patient expected to be discharged from the hospital within 24 hours
Prisoner
Trial design
Treatments tested in this trial
- Ultrasound Guided Central Venous Catheter
- Ultrasound Guided Midline Catheter
Treatment groups
100 Participants
are divided into 2 treatment groupsSponsors and collaborators
Albert Einstein College of Medicine
Lead sponsor
Jacobi Medical Center
Collaborator
Source ClinicalTrials.gov